Cargando…

Strategies for Cardio-Oncology Care During the COVID-19 Pandemic

PURPOSE OF REVIEW: The COVID-19 pandemic has disrupted healthcare and has disproportionately affected the marginalized populations. Patients with cancer and cardiovascular disease (cardio-oncology population) are uniquely affected. In this review, we explore the current data on COVID-19 vulnerabilit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abraham, Sonu, Manohar, Shamitha Alisa, Patel, Rushin, Saji, Anu Mariam, Dani, Sourbha S., Ganatra, Sarju
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Cardio-oncology (M Fradley, Section Editor)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446588/ https://www.ncbi.nlm.nih.gov/pubmed/36090762 http://dx.doi.org/10.1007/s11936-022-00965-2

Ejemplares similares

Cardiotoxicity of Contemporary Anticancer Immunotherapy
por: Dal’bo, Natalie, et al.
Publicado: (2020)

Cardiotoxicity of T-Cell Antineoplastic Therapies: JACC: CardioOncology Primer
por: Ganatra, Sarju, et al.
Publicado: (2022)

Disparities in Cardio-oncology: Effects On Outcomes and Opportunities for Improvement
por: Ahmad, Javaria, et al.
Publicado: (2022)

Innovations in Cardio-oncology Resulting from the COVID-19 Pandemic
por: Kondapalli, Lavanya, et al.
Publicado: (2022)

Cardio-oncology Training in the COVID-19 Era
por: Feldman, Stephanie, et al.
Publicado: (2021)

Cardiotoxicity of Immune Checkpoint Inhibitors
por: Patel, Rushin P., et al.
Publicado: (2021)

Permissive Cardiotoxicity: The Clinical Crucible of Cardio-Oncology
por: Porter, Charles, et al.
Publicado: (2022)

Cardiovascular Complications of Hematopoietic Stem Cell Transplantation
por: Blaes, Anne, et al.
Publicado: (2016)

Role of Biomarkers in Prediction of Cardiotoxicity During Cancer Treatment
por: Tan, Li-Ling, et al.
Publicado: (2018)

Pericardial Disease in Cancer Patients
por: Ghosh, Arjun K., et al.
Publicado: (2018)

Cardio-oncology in 2022
por: Dobson, Rebecca
Publicado: (2023)

The 2022 European Society of Cardiology Cardio-oncology Guidelines in Focus
por: Gent, David G, et al.
Publicado: (2023)

Cardiac Computed Tomography in Cardio-Oncology: JACC: CardioOncology Primer
por: Lopez-Mattei, Juan C., et al.
Publicado: (2021)

Strain Imaging in Cardio-Oncology
por: Liu, Jennifer E., et al.
Publicado: (2020)

Cardio‐Oncology at the Beginning of a New Decade
por: Grumbach, Isabella M.
Publicado: (2020)

Advanced Imaging Modalities to Monitor for Cardiotoxicity
por: Seraphim, Andreas, et al.
Publicado: (2019)

Cardiotoxicities of 5-Fluorouracil and Other Fluoropyrimidines
por: Shiga, Taro, et al.
Publicado: (2020)

Advances in the Treatment of Cardiac Amyloidosis
por: Macedo, Ariane Vieira Scarlatelli, et al.
Publicado: (2020)

Metabolic Aspects of Anthracycline Cardiotoxicity
por: Russo, Michele, et al.
Publicado: (2021)

Cardiovascular Toxicities of Androgen Deprivation Therapy
por: Challa, Azariyas A., et al.
Publicado: (2021)

Primer on Biomarker Discovery in Cardio-Oncology: Application of Omics Technologies
por: Rhee, June-Wha, et al.
Publicado: (2020)

Reverse Cardio‐Oncology: Cancer Development in Patients With Cardiovascular Disease
por: Aboumsallem, Joseph Pierre, et al.
Publicado: (2020)

Racial and Ethnic Disparities in Cardio-Oncology: A Call to Action
por: Fazal, Muhammad, et al.
Publicado: (2021)

The Evolving Immunotherapy Landscape and the Epidemiology, Diagnosis, and Management of Cardiotoxicity: JACC: CardioOncology Primer
por: Zhang, Lili, et al.
Publicado: (2021)

Cardioprotection in Patients at High Risk of Anthracycline-Induced Cardiotoxicity: JACC: CardioOncology Primer
por: Henriksen, Peter A., et al.
Publicado: (2023)

Cardiac Magnetic Resonance in Cardio-Oncology: Advantages, Importance of Expediency, and Considerations to Navigate Pre-Authorization
por: O’Quinn, Rupal, et al.
Publicado: (2021)

Cardio-oncology: Shared Genetic, Metabolic, and Pharmacologic Mechanism
por: Zhao, Yiqi, et al.
Publicado: (2023)

Potential Applications for Targeted Gene Therapy to Protect Against Anthracycline Cardiotoxicity: JACC: CardioOncology Primer
por: Kok, Cindy Y., et al.
Publicado: (2021)

Developing a Model for Cross-Institutional Educational Collaborations: The Chicago Cardio-Oncology Consortium (CCC) Experience
por: Minga, Iva, et al.
Publicado: (2023)

The COVID-19 Pandemic and its Impact on the Cardio-Oncology Population
por: Asokan, Ishan, et al.
Publicado: (2020)

Reaching Across the Aisle: Cardio-Oncology Advocacy and Program Building
por: Sadler, Diego, et al.
Publicado: (2021)

Dyspnoea in Oncological Patients: A Brain Teaser
por: Keramida, Kalliopi, et al.
Publicado: (2023)

Cardiovascular Disease in Adult Cancer Survivors: a Review of Current Evidence, Strategies for Prevention and Management, and Future Directions for Cardio-oncology
por: Muhandiramge, Jaidyn, et al.
Publicado: (2022)

The Role and Impact of Social Media in Cardio-oncology During the COVID-19 Pandemic
por: Kwan, Jennifer M., et al.
Publicado: (2021)

Recent Advances in Serum Biomarkers for Risk Stratification and Patient Management in Cardio-Oncology
por: Joolharzadeh, Pouya, et al.
Publicado: (2023)

Modeling Precision Cardio-Oncology: Using Human-Induced Pluripotent Stem Cells for Risk Stratification and Prevention
por: Perry, Tatiana R., et al.
Publicado: (2021)

Mitochondrial Dynamin-Related Protein Drp1: a New Player in Cardio-oncology
por: Deng, Yali, et al.
Publicado: (2022)

LVEF by Multigated Acquisition Scan Compared to Other Imaging Modalities in Cardio-Oncology: a Systematic Review
por: Printezi, Markella I., et al.
Publicado: (2022)

Editorial commentary: Cardiovascular imaging in COVID-19: Focus on safety, value, and clinical relevance
por: Dani, Sourbha S., et al.
Publicado: (2021)

Cardiovascular Drug Interactions With Nirmatrelvir/Ritonavir in Patients With COVID-19: JACC Review Topic of the Week
por: Abraham, Sonu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pnoe70bgpg0bcc1aafiksq5i7l